The machine learning system SCORPIO can predict patient outcomes with immune checkpoint inhibitor (ICI) therapy across ...

An AI foundation model capable of predicting gene activity across many different human cell types may expedite research for ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Platforms using natural language processing are showing promise in scanning patients' records for biomarkers and other enrollment criteria for clinical trials.

OXcan was founded in 2020 by Dr. Peter Jianrui Liu and Dr. Andreas Halner to advance early cancer detection using liquid biopsy.

Researchers at Newcastle University in the UK have developed a groundbreaking tool called “DeepMerkel,” powered by artificial ...

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

A new artificial intelligence tool combines data from medical images with text to predict cancer prognoses and treatment responses.

Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it has raised US$11 million in Series A funding ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Researchers at Stanford Medicine developed MUSK, an AI model that integrates visual and text-based medical data to improve ...